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Abstract 
 
We evaluated the effect of Paris saponin on inhibition of cervical cancer in mice and on immune regulation in 
tumor-bearing mice.  MTT assay was used to examine the effect of Paris saponin on U14 cell proliferatiosn in vitro; the ascites 
tumor model of U14 cervical cancer was established to observe the effect of Paris saponin on inhibition of the tumor and on 
survival time of mice; and serum IL-4 and IFN-γ levels in tumor-bearing mice were detected. The Paris saponin showed 
significant inhibitory effect on growth of cervical cancer U14 cells both in vitro and in vivo, prolonged the survival time of 
mice, increased the serum IFN-γ level of tumor-bearing mice, and reduced the serum IL-4 level. The Paris saponin can inhibit 
U14 cell growth and prolong survival time of mice; it is speculated that the Paris saponin may express its anti-tumor activity by 
improving the body's immune system.   
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Introduction 
 
Rhizoma Paridis is the dried rhizome of Paris polyphylla Smith var. yunnanensis (Franch.) Hand.-Mazz. or Paris 
polyphylla Smith var. chinensis (Franch.) Hara, which belongs to the Liliaceae plant family (Chinese 
Pharmacopoeia Commission,. 2010). It is bitter, slightly cold, mildly toxic, and can clear heat and remove toxicity, relieve 
swelling and pain, cool the liver and arrest convulsion. Pharmacological studies have found that its active ingredients have the 
haemostatic effect (Fu, 2007), anti-tumor effect  (Liu, 2008), antibacterial effect (Li, 2009), anti-inflammatory effect  (Zhang, 
2008), brain and kidney protection effect (Huang, 2008), antioxidant effect (Gao, 2007), and uterine contraction effect (Cong, 
2005). At present, the chemical constituents extracted from Rhizoma Paridis are mainly steroidal saponins and free amino acids, 
of which Paris saponins account for approximately 80% of the total number of compounds, most of them are diosgenin, which 
is an active anti-tumor ingredient, including Paris saponin I (diosgenin 3-O-α-L-rha-(1-2)-[α-L-arab-(1-4)]-β-D-glu),Paris 
saponin II (diosgenin3-O-α-rha-(1-4)-α-L-rha-(1-4)-[α-L-rha-(1-2)]-β-D- 
glu), Paris saponin III, diosgenin and C22-hydroxy-protodioscin, C22-methoxy-protodioscin, C22-hydroxy-protopolyphyllin I, 
C22-methoxy-protopolyphyllin I, C22-methoxy- protopolyphyllin II, etc. (Wu., 2004).  Isolated  PSII  has  potent  inhibitory 
effects on the growth of tumor cells without deleterious effects on different normal cell types or benign neoplastic derived 
cells. (Xiao et al., 2012). 
 
Materials and methods 
Medicinal materials 
 
Rhizoma Paridis was purchased from Dalian Baidu Pharmaceutical Company. 
GuanLie Afr J Tradit Complement Altern Med. (2013) 10(3):503-507 
http://dx.doi.org/10.4314/ajtcam.v10i3.17 
504
Apparatuses and reagents 
 
Refrigerated centrifuge (Eppendorf, Germany), clean bench (Suzhou Purification Equipment Co., Ltd.), CO2 incubator 
(SANYO, Japan), continuous wavelength microplate reader (Bio-RAD), electronic balance (Shanghai Precision Instrument Co., 
Ltd.), IFN-γ and IL-4 ELISA test kit (purchased from Nanjing Jiancheng Reagent Company), MTT (purchased 
from Sigma-Aldrich Corp), cyclophosphamide (purchased from Jiangsu Hengrui Medicine Co., Ltd.) 
 
Cell lines and experimental animals 
 
Cervical cancer cell lines (U14) was purchased from the Chinese Academy of Medical Sciences. Female Kunming mice 
weighing 18 ± 2 g were purchased from the Laboratory Animal Center of Dalian Medical University. 
 
Preparation of Paris saponin extract 
 
Referencing to the method of Zhu Li-li (Zhu., 2006), Rhizoma Paridis was soaked in a 10-fold amount of 70 % ethanol 
overnight, and extracted three times with heat reflux extraction at 88 oC for 4 hours, the filtrates were combined and ethanol 
was recovered, then they were dried in vacuo and Rhizoma Paridis total saponins were obtained. 
 
In vitro experiment 
 
The intraperitoneally passaged ascites were extracted from mice under sterile conditions using MTT assay, dispersed into 
single cell suspension using culture solution, seeded in a 96-well plate with 100 μl each well, and cultured for 24 
hours. Culture solution was discarded, and drug-containing culture medium was added (three replicate wells for each drug 
concentration). Meanwhile, blank control group which was only added with the complete culture solution was set up. After 
culturing in a 37 oC incubator with 5 % CO2 and saturated humidity for 48 h and 72 h, each well was added with 20 μL of MTT 
solution, the culturing was continued for an additional 4 h, then the supernatant was discarded. 150 μL of DMSO was added to 
each well, and the plate was shaken in a micromixer for 10 min, after the crystalline particles were fully dissolved, absorbance 
value (A value) of each hole was measured at 490 nm, and the growth inhibition rate (IR) was calculated according to the 
following formula:Cell growth inhibition rate (%) = (1 - average A value of drug group / average A value of control 
group) × 100.  
 
In vivo test (Li et al, 2009) 
 
The intraperitoneally passaged ascites were extracted from mice under sterile conditions, the concentration of collected 
cells was adjusted to 1×106/mL using sterile saline solution, and 0.2 ml was inoculated intraperitoneally into each mouse. 24 
h after inoculation, the mice were weighed, grouped and administered; mice were randomly divided into 5 groups, with 
10 mice in each group, they were negative control group, positive control group as well as Paris saponin high- and low-dose 
treatment groups respectively. Positive control group was administered by intraperitoneal injection of 20 mg/kg of 
cyclophosphamide according to body weight, negative control group was intragastrically administered normal saline, and Paris 
saponin high- and low-dose groups were intragastrically administered 100 mg/kg and 50 mg/kg of Paris saponin respectively 
according to body weight for 8 consecutive days. On the 9th day, mice were blood-sampled from eyeballs and sacrificed, 
ascites of each group were extracted, and the number of ascites tumor cells was counted. 
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IFN-γ and IL-4 levels in serum of tumor-bearing mice  
 
Blood was sampled from eyeballs of mice in experimental groups and control groups, and centrifuged at 3000  
r/min for 20 min, serum was collected, and IFN-γ and IL-4 levels in serum of each group were measured according to kit 
instructions. 
 
Effect of Paris saponin on survival time of tumor-bearing mice 
 
Modeling and grouping method was as described above, after continuous administration for 15 days and drug withdrawal, 
survival time of mice in each group was recorded, and life prolongation rate was calculated according to the following formula. 
 
Life prolongation  rate (%)  = [(mean survival  time  of  mice  in  drug  treatment  group ‐ mean survival  time  of  mice  in 
negative control group) / mean survival time of mice in negative control group] × 100. 
 
Statistical analysis 
 
The results obtained were analyzed using Origin 7.5 statistical software. 
 
Results 
 
The results for in-vitro inhibitory effect of Paris saponin on U14 cells are as follows. The results showed that different 
doses of Paris saponin (5μg/ml-80μg/ml) had inhibitory effect on U14 cells in vitro, in a concentration-dependent manner, 
inhibition rate increased with increasing of concentrations, at the same time, it also had certain time-dependency, which was 
significantly different (p<0.05) compared with the control group (Table 1).  
 
Table 1: Inhibitory effect of Paris saponin on U14 cells 
                                 Treatment time (h) 
48 72  
Concentration (μg/ml) Inhibition rate (%) Inhibition rate (%) 
      Control group   
15.12 7.48 
24.75 31.41 
57.65 67.15 
67.47 74.55 
5 
10 
20 
40 
80 71.22 76.35 
 
   The results for in-vivo anti-tumor effect of Paric saponin in U14 ascites tumor bearing mice are shown in Table 2. 
The results showed that, after intragastric administration of different doses of Paris saponin in tumor-bearing mice, numbers of 
ascites tumor cells in mice were all significantly reduced, which were significantly different compared with the negative 
control group, indicating that Paris saponin had an anti-tumor effect in vivo. 
Table 2: Effect of Paris saponin on inhibition of in-vivo ascites tumor growth (
—
X ±S) 
Number of animals Group Drug 
concentration (mg/k Start End 
Number of tumor 
cells×108cell/ml 
Inhibition 
rate (%) 
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g) 
Control group Normal saline 10 10 8.10±0.42  
Cyclophosphamide 20 10 10 2.72±0.34** 66.4 
50 10 10 4.78±0.24** 41.0 Paridis total saponins 
100 10 10 3.91±0.56** 51.7 
Note: Comparison with the negative control group, ** P<0.01 
 
The results for effect of Paris saponin on serum IFN-γ and IL-4 levels in tumor-bearing mice are as follows (Table 3). 
Table 3: Effect of Paris saponin on serum IFN-γ and IL-4 levels in tumor-bearing mice ( X ±S) 
Group Drug concentration 
mg/kg 
IFN-γ  
pg/ml 
IL-4  
pg/ml 
Control Normal saline 81.57±7.16 13.84±2.74 
Cyclophosphamide  20 76.11±8.45 14.94±2.96 
50 61.71±6.78** 19.87±2.77** Paris saponin  
100 47.36±7.15** 21.57±2.89** 
Note: Comparison with the negative control group, ** P<0.01 
 
The results show that, compared with the negative control group, serum IFN-γ level in mice of Paris saponin group 
significantly increased, while IL-4 level significantly decreased. 
 
Effect on survival time of mice 
Table 4: Effect of Paris saponin on survival time of tumor-bearing mice ( X ±S) 
Group 
Drug 
concentration (mg/kg) 
Number of 
animals 
Survival time 
(Days) 
Life prolongation 
rate 
(%) 
Control Normal saline 10 14.4±1.8 - 
Cyclophosphamide  20 10 26.7±2.5** 85.4 
50 10 19.6±1.9* 36.1 Paris saponin 
Paris saponin 100 10 23.4±2.0** 62.5 
Comparison with the negative control group, *P<0.05, **P<0.01 
Compared with the negative control group, survival times of mice in cyclophosphamide group and Paris saponin group 
were significantly prolonged; mean survival times in Paris saponin groups were 19.6±1.9 and 23.4±2.0 d, and life prolongation 
rates were 36.1 % and 62.5 % respectively. 
 
 
 
Discussion 
 
The experimental results show that the Paris saponin had significant inhibitory effect on U14 cells in vitro, while in vivo, 
it could also significantly inhibit number of tumor cells in tumor-bearing mice; in addition, serum IFN-γ level in mice was 
significantly increased, while IL-4 level was significantly reduced, thereby activating the immune cells to generate immune 
responses. It is probable that the tumor inhibition effect of Paris saponin is achieved via activation of immune factors in the 
body (Li., 2008). 
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Many literatures have reported that the antitumor mechanism of Rhizoma Paridis may be through the inhibition of protein 
and DNA synthesis in tumor cells, inhibition of tumor cell mitosis, thereby inhibiting cell proliferation (Li., 2010), regulation 
of the body's immune (Bian et al, 2002) as well as induction of apoptosis and anti-angiogenesis (Lee et al, 2006; Shimizu et al, 
2005; Hu et al, 2008). Rhizoma Paridis has complex chemical composition, and varied pharmacological effects, especially the 
tumor inhibition effect; clinical researches on active ingredients of Rhizoma Paridis should be carried out for the development 
and use of Rhizoma Paridis. 
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